advertisement
11.3.4 Betablocker (15)
Showing records 1 to 15
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker11308 A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients
Tomita G; Araie M; Kitazawa Y; Tsukahara S
Eye 2004; 18: 984-989
11307 Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye 2004; 18: 990-995
11374 Comparison of once-daily nonpreserved timolol and timolol maleate gel-forming solution associated with latanoprost
Bron A; Velasque L; Rebica H; Pouliquen P; Elena PP; Rouland JF
Journal Français d'Ophtalmologie 2004; 27: 971-977
11573 Timolol topical ophthalmic combination
Calugaru M; Calugaru D
Oftalmologia 2004; 48: 5-14
11302 Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies
Hamacher T; Schinzel M; Scholzel-Klatt A; Neff HM; Maier H; Schlaffer G; Beausencourt E; Jutte M; Scholz R; Lorger C
British Journal of Ophthalmology 2004; 88: 1295-1298
11305 Short and long-term hypotensive effect of timolol-gel and latanoprost instillation in normal-tension glaucoma
Hashimoto T; Hara T; Takahashi Y; Kubota S; Kubota M; Tsuru T
Nippon Ganka Gakkai Zasshi 2004; 108: 477-481
11464 Preventive effect of lacrimal occlusion on topical timolol-induced bronchoconstriction in asthmatics
Hepsen IF; Yildirim Z; Yilmaz H; Kotuk M
Clinical and Experimental Ophthalmology 2004; 32: 597-602
11555 Influence of topical beta blockers and preservatives on the ocular surface and tear fluid
Ishioka M; Shimazaki J; Yagi Y; Tsubota K
Japanese Journal of Clinical Ophthalmology 2004; 58: 1437-1440
11300 Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%
Konstas AGP; Kozobolis VP; Lallos N; Christodoulakis E; Stewart JA; Stewart WC
Eye 2004; 18: 1264-1269
11228 Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma
Konstas AGP; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
Eye 2004; 18: 893-899
11303 Comparison of the nocturnal effects of once-daily timolol and latanoprost onintraocular pressure
Liu JH; Kripke DF; Weinreb RN
American Journal of Ophthalmology 2004; 138: 389-395
11306 Comparison of the effects of latanoprost and timolol gel-forming solution on diurnal variation of intraocular pressure in normal-tension glaucoma
Nakamoto K; Yasuda N; Nanno M; Fukuda T
Nippon Ganka Gakkai Zasshi 2004; 108: 401-407
11296 Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs
Osborne NN; Wood JP
Investigative Ophthalmology and Visual Science 2004; 45: 3787-3795
11575 Binding affinities of ocular hypotensive β-blockers levobetaxolol, levobunolol, and timolol at endogenous guinea pig β-adrenoceptors
Sharif NA; Xu SX
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 93-99
11298 Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: Three-month comparison of efficacy and safety
Martinez De La Casa JM; Castillo A; Garcia Feijoo J; Mendez Hernandez C; Fernandez Vidal A; Garcia Sanchez J
Current Medical Research and Opinion 2004; 20: 1333-1339
